Martin Fan
Stock Analyst at Wedbush
(4.91)
# 270
Out of 4,556 analysts
49
Total ratings
75.6%
Success rate
84.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Martin Fan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RNAC Cartesian Therapeutics | Maintained: Buy | $38 | $8.13 | +367.40% | 6 | Jun 10, 2026 | |
| ARTV Artiva Biotherapeutics | Maintained: Buy | $40 | $10.02 | +299.20% | 3 | May 21, 2026 | |
| TRAX First Tracks Biotherapeutics | Maintained: Buy | $30 | $38.17 | -21.40% | 2 | May 15, 2026 | |
| FATE Fate Therapeutics | Maintained: Buy | $7 | $2.58 | +171.32% | 4 | May 14, 2026 | |
| VOR Vor Biopharma | Maintained: Hold | $15 → $18 | $19.51 | -7.74% | 3 | May 14, 2026 | |
| SANA Sana Biotechnology | Maintained: Buy | $7 | $3.12 | +124.36% | 4 | May 13, 2026 | |
| NKTR Nektar Therapeutics | Maintained: Hold | $95 → $80 | $69.32 | +15.41% | 3 | May 11, 2026 | |
| IMA ImageneBio | Maintained: Sell | $2 | $5.97 | -66.50% | 3 | May 11, 2026 | |
| ACRS Aclaris Therapeutics | Maintained: Buy | $10 | $5.62 | +77.94% | 7 | May 8, 2026 | |
| ZURA Zura Bio | Maintained: Buy | $15 | $5.40 | +177.78% | 3 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $39.30 | +17.05% | 1 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 → $45 | $92.53 | -51.37% | 4 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $31.49 | +42.90% | 4 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $45 | $52.61 | -14.46% | 2 | Aug 7, 2025 |
Cartesian Therapeutics
Jun 10, 2026
Maintained: Buy
Price Target: $38
Current: $8.13
Upside: +367.40%
Artiva Biotherapeutics
May 21, 2026
Maintained: Buy
Price Target: $40
Current: $10.02
Upside: +299.20%
First Tracks Biotherapeutics
May 15, 2026
Maintained: Buy
Price Target: $30
Current: $38.17
Upside: -21.40%
Fate Therapeutics
May 14, 2026
Maintained: Buy
Price Target: $7
Current: $2.58
Upside: +171.32%
Vor Biopharma
May 14, 2026
Maintained: Hold
Price Target: $15 → $18
Current: $19.51
Upside: -7.74%
Sana Biotechnology
May 13, 2026
Maintained: Buy
Price Target: $7
Current: $3.12
Upside: +124.36%
Nektar Therapeutics
May 11, 2026
Maintained: Hold
Price Target: $95 → $80
Current: $69.32
Upside: +15.41%
ImageneBio
May 11, 2026
Maintained: Sell
Price Target: $2
Current: $5.97
Upside: -66.50%
Aclaris Therapeutics
May 8, 2026
Maintained: Buy
Price Target: $10
Current: $5.62
Upside: +77.94%
Zura Bio
May 8, 2026
Maintained: Buy
Price Target: $15
Current: $5.40
Upside: +177.78%
Feb 26, 2026
Reiterated: Buy
Price Target: $46
Current: $39.30
Upside: +17.05%
Jan 13, 2026
Maintained: Buy
Price Target: $42 → $45
Current: $92.53
Upside: -51.37%
Dec 22, 2025
Maintained: Buy
Price Target: $45
Current: $31.49
Upside: +42.90%
Aug 7, 2025
Maintained: Buy
Price Target: $40 → $45
Current: $52.61
Upside: -14.46%